Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

KEY POINTS

KEY POINTS

  1. Inborn errors of metabolism (IEM) are rare disorders, most of them only present after delivery.

  2. Several IEMs may affect the fetus, producing congenital malformations and/or brain insults.

  3. Prenatal diagnosis is usually possible following the birth of an affected child; in patients without a family history, even in the presence of severe malformations, a definitive diagnosis is usually only made after delivery.

  4. Biochemical tests and molecular studies are indicated in selected cases.

DIAGNOSTIC APPROACH

  • In patients at risk: Systematic search for positive characteristic findings, use the checklist approach.

  • In low-risk patients: Individualized approach according to specific findings.

  • Remember: IEM is usually a diagnosis of exclusion.

Differential Diagnosis

  • Chromosomal disorders

  • Single gene syndromes

  • Prenatal infections

  • Teratogens

Background

The in utero metabolic microenvironment during embryogenesis (fetal metabolome) profoundly influences the entire range of developmental processes underlying fetal organogenesis.

Inborn errors of metabolism (IEMs) are inherited disorders with mostly single gene defects resulting in the development of enzymatic blocks within biochemical pathways, often due to the deficiency of an enzyme or cofactor. There may be secondary accumulation or formation of toxic intermediaries as well as deficiency of critical end products necessary for cell function. The resulting changes influence the internal and external cellular microenvironment as well as cellular homeostatic mechanisms.1 The association of IEMs with developmental malformations has long been recognized (Figure 16–1). Following initial reports of association of callosal dysgenesis with IEMs,2 widespread developmental abnormalities in the morphogenesis of the brain have been described.3 A logical extension of these observed associations is the exploration of the possibilities of detection and diagnosis during the prenatal period. A majority of these conditions are usually diagnosed in postnatal life in the index case. During subsequent pregnancies, early detection and diagnosis carries the potential for early therapeutic interventions in the fetus or carefully considered decisions to terminate the pregnancy in the event of the diagnosis of an incurable disorder with no hope for a meaningful quality of life.

Figure 16–1.

Markers of IEM’s on fetal neurosonography.

A variety of interactions between the planes of genome–proteome and metabolome regulate developmental processes that ultimately influence the formation and maturation of all organ systems, including the fetal brain. In early fetal life, interference with formation of the telencephalic vesicles (holoprosencephaly), dysgenesis of the corpus callosum, absence of the septi pellucidi, cerebellar dysgenesis, and abnormalities in ventricular shape (colpocephaly, single ventricle) may be visualized through targeted neurosonography. As the brain grows in complexity, abnormalities may extend to involve the gray matter (atrophy of the cortical ribbon, atrophy of the basal ganglia), white matter (thinning out or loss of volume, demyelination, or dysmyelination of white matter), encephaloclastic lesions (porencephalic cysts), and neuronal ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.